Source: Eur Respir J 2011; 38: 981-983
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Imaoka H., Gauvreau G.M., Watson R.M., Smith S.G., Dua B., Baatjes A.J., Howie K., Hoshino T., Killian K.J., Aizawa H., O’Byrne P.M.. Interleukin-18 and interleukin-18 receptor-? expression in allergic asthma. Eur Respir J 2011; 38: 981-983

Member's Comments

No comment yet.

Related content which might interest you: Interleukin-18, interleukin-12, interferon γ and interleukin-18 receptor expression is decreased in the recovery phase of pulmonary sarcoidosis Source: Eur Respir J 2001; 18: Suppl. 33, 366s Year: 2001 Serum levels of interleukin-18 in patients affected by allergic bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 30s Year: 2002 Serum levels of IL-8, IL-10 and TNFα in severe allergic asthma Source: Eur Respir J 2005; 26: Suppl. 49, 279s Year: 2005 IL-10 and IL-1ra mediates OVA-induced Th2 airway allergic response at short and long-term Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury Year: 2013 Interleukin-12 receptor mRNA expression and corticosteroid depended eosinophil apoptosis in asthma Source: Eur Respir J 2003; 22: Suppl. 45, 223s Year: 2003 Exacerbation of experimental asthma depends on IL-6 but not on IL-23 or ROR?t Source: International Congress 2017 – Animal models of asthma and allergies Year: 2017 Caspase-1 induces upstream Th2-cytokines IL-33 and TSLP and eosinophilia at viral induced asthma exacerbations Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding Year: 2016 Cytokine modulators as novel therapies for airway disease Source: Eur Respir J 2001; 18: 67S-77S Year: 2001 Neutraligands of CXCL12: Anti-inflammatory activity in an allergic model of asthma Source: Annual Congress 2011 - Models of disease and drug actions Year: 2011 IL-33 augments rhinovirus-induced type 2 immune responses in asthma via selective upregulation of one chain of the IL-33 receptor. Source: International Congress 2017 – "Alarming" immunological patterns in asthma Year: 2017 Interleukin-17 cytokine signalling in patients with asthma Source: Eur Respir J 2014; 44: 1319-1331 Year: 2014 Implication of interleukin-18 in airway remodelling in refractory asthma Source: Annual Congress 2011 - Asthma: basic science and clinical studies Year: 2011 Implication of interleukin-18 in airway remodelling in refractory asthma Source: Annual Congress 2010 - Cough, airway hyperresponsiveness and asthma control Year: 2010 Induced sputum free interleukin-5 level and its mRNA expression in atopic asthma Source: Eur Respir J 2003; 22: Suppl. 45, 548s Year: 2003 Role of CCL21 and CCL19 in allergic inflammation examined by murine asthmatic model Source: Annual Congress 2006 - Immunology of the airways Year: 2006 Serum TNF-a, IL-12 and IL-13 levels in severe bronchial asthma patients Source: Eur Respir J 2004; 24: Suppl. 48, 353s Year: 2004 Interleukin-4 and interleukin-5 are increased in asthma early in the course of the disease Source: Eur Respir J 2007; 30: Suppl. 51, 139s Year: 2007 High-level expression of PD-L1 by DC suppresses airway inflammation in OVA-induced allergic asthma Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010